Cinda Pharmaceutical currently has 1 national first-class drugs and 3 national second-class drugs. Xindaluo, Aiker, Bonner, Pfeiffer and other products are among the best in the domestic market share, making Xinda Pharmaceutical a famous production base of oral anti-infective drugs and children's drugs in China, and also an important production base of middle-aged and elderly drugs in China from 65438 to 0994. Xinda Pharmaceutical took the lead in introducing and developing the antibacterial drug "Xindaluo", which ranked first in the world for prescription drugs for ten consecutive years, and then introduced Xianfeng IX, Xindabao and. At present, the company's anti-infective drugs have covered cephalosporins, penicillins, macrolides, quinolones and other broad-spectrum antibiotics and antiviral drugs, anti-anaerobic bacteria and protozoa drugs, drugs for treating bacterial infectious enteritis and diarrhea and other fields. With cephalosporin antibiotics for children as the leading product, Xinda Pharmaceutical has successively launched Xindaluo Granules, Xianfeng Nine Granules, Xiaoer Tuifei Granules and li jinxi, which has become an important production base for children's drugs in China. In the field of non-communicable chronic diseases of middle-aged and elderly people, Xinda Pharmaceutical has developed a national first-class antidiabetic drug Dunling, a national second-class antihypertensive drug Nierxin, a drug for treating Alzheimer's disease and a drug for treating benign prostatic hyperplasia Shiyi. In terms of specialized drugs, the company has new products such as pravastatin, a non-steroidal anti-inflammatory drug, Xinkaite, an antiemetic drug for tumor radiotherapy and chemotherapy, Goody, a gastrointestinal motility drug, Gracie and so on.